sur INTRASENSE (EPA:ALINS)
Intrasense Revenue Rises 43% in 2025
In 2025, Intrasense reported a 43% increase in annual revenue, reaching €3.2 million, aligning with their annual targets. This growth was largely driven by the strong performance of the Myrian® product line internationally.
The company achieved significant order intake, totaling over €6.1 million, securing a backlog of more than €3.0 million for 2026-2029. Intrasense's geographical revenue breakdown shows growth in Europe by 316% and in France by 13%. However, revenue in China decreased by 39% amidst ongoing divestment activities.
Intrasense's strategic roadmap included obtaining CE markings for Myrian® 2.14.x and the DUOnco™ range, contributing to product portfolio value. The company plans to continue its participation in major radiology events in 2026 to further promote its innovations and engage with industry partners.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de INTRASENSE